AP-2α Regulates S-Phase and Is a Marker for Sensitivity to PI3K Inhibitor Buparlisib in Colon Cancer.
Beck AC, Cho E, White JR, Paemka L, Li T, Gu VW, Thompson DT, Koch KE, Franke C, Gosse M, Wu VT, Landers SR, Pamatmat AJ, Kulak MV, Weigel RJ.
Beck AC, et al. Among authors: gosse m.
Mol Cancer Res. 2021 Jul;19(7):1156-1167. doi: 10.1158/1541-7786.MCR-20-0867. Epub 2021 Mar 22.
Mol Cancer Res. 2021.
PMID: 33753551
Free PMC article.